2024-11-05 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis

**1) Stock Performance Analysis:**

Intuitive Surgical Inc. (ISRG) is a company that develops, manufactures, and markets robotic surgical systems. 

- ISRG's cumulative return is **364.21%**, compared to the S&P 500 (VOO) cumulative return of **131.78%**. This indicates a significant outperformance of ISRG.
- The **outperformance gap** between ISRG and the S&P 500 is **232.43%**, which is currently at the **80.15th percentile** based on historical data. 
- **Alpha** and **Beta** analysis shows that ISRG consistently outperformed the market (positive alpha) with varying degrees of volatility (beta). 
    - **Alpha** indicates the stock's performance compared to the benchmark, while **beta** measures the stock's volatility relative to the market.

**2) Recent Price Movement:**

- **Closing Price**: 506.34 (Last-market: 509.13)
- **5-day Moving Average**: 510.23
- **20-day Moving Average**: 498.58
- **60-day Moving Average**: 488.1

The stock is currently trading above its 5-day, 20-day, and 60-day moving averages, suggesting short-term bullish momentum.

**3) Technical Indicators:**

- **RSI**: 60.18
- **PPO**: 0.01
- **Delta_Previous_Relative_Divergence**: 6.22 (+)
- **Expected Return**: 12.54%

The RSI indicates the stock is in a neutral range, not overbought or oversold. The positive Delta_Previous_Relative_Divergence suggests a short-term upward trend. The PPO is close to zero, indicating a neutral trend.

**4) Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2023-10-18 | 1.18 | 1.74 B$ |

Intuitive Surgical consistently exceeded revenue and EPS expectations in recent quarters. The company continues to benefit from the increasing adoption of robotic surgery in the medical field.

**5) Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30  | $2.04B | 67.41% |
| 2024-06-30  | $2.01B | 68.30% |
| 2024-03-31  | $1.89B | 65.87% |
| 2023-12-31  | $1.93B | 66.24% |
| 2023-09-30  | $1.74B | 66.94% |

**2) Capital and Profitability:**

| Quarter  | Equity   | ROE |
|---|---|---|
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |
| 2023-09-30 | $12.54B | 3.32% |

Intuitive Surgical demonstrates strong revenue growth and consistent profitability with high profit margins. The company also has a strong financial position with a significant equity base.

**6) News and Recent Issues:**

- The recent earnings release on **October 18, 2024**, showed that Intuitive Surgical exceeded expectations on both revenue and earnings per share. Analysts were impressed by the strong growth in the da Vinci surgical system segment.

- **FINBOLD** reports a positive market outlook for ISRG, with analysts predicting a 10-15% growth in revenue in the coming years.

- **Recent analyst opinions** highlight the company's dominant market share, strong growth in the surgical robotics market, and its increasing presence in emerging markets.

**7) Overall Analysis:**

ISRG continues to be a strong performer, demonstrating robust revenue growth, high profitability, and a dominant market position in the surgical robotics market. Its consistent outperformance against the S&P 500 is a positive indicator. The recent earnings beat and positive analyst sentiment suggest a favorable market outlook. The expected return of 12.54% over the long term makes ISRG an attractive investment option for investors seeking long-term growth.

**Note:** This analysis is based on the provided data and is not financial advice. It is essential to consult with a financial professional before making any investment decisions.